MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE

Clinical trials for MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE explained in plain language.

Never miss a new study

Get alerted when new MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE trials appear

Sign up with your email to follow new studies for MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

First patients receive new experimental drug targeting genetic cause of ALS

Disease control Recruiting now

This is the first study to test an experimental drug called ALN-SOD in people with ALS caused by a specific change in the SOD1 gene. The main goal is to check the drug's safety and how well it's tolerated when given via spinal injection. Researchers will also measure how the drug…

Matched conditions: MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE

Phase: PHASE1, PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE

Get alerted when new MUTATION IN THE SUPEROXIDE DISMUTASE-1 (SOD1) GENE trials appear

First patients receive new experimental drug targeting genetic cause of ALS